Two Sigma Investments, LP Acrivon Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

$50.6 Billion
Q2 2025

A detailed history of Two Sigma Investments, LP transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 181,172 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

181,172

Holding current value

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Aug 14, 2025	BUY	N/A	181,172 New	181,172 $0
Q4 2022 Feb 14, 2023	BUY	N/A	21,534 New	21,534 $0

Others Institutions Holding ACRV

# of Institutions

Shares Held

18.5M

Call Options Held

Put Options Held

Ra Capital Management, L.P. Boston, MA

8.34M
Shares

$0
0.0% of portfolio
Sands Capital Ventures, LLC Arlington, VA

2.12M
Shares

$0
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

1.9M
Shares

$0
0.0% of portfolio
Wellington Management Group LLP Boston, MA

888K
Shares

$0
0.0% of portfolio
Black Rock Inc. New York, NY

767K
Shares

$0
0.0% of portfolio

View Full List

About Acrivon Therapeutics, Inc.

Ticker ACRV

More about ACRV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Acrivon Therapeutics, Inc. Transaction History